FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3021855132> ?p ?o ?g. }

• W3021855132 endingPage "2220" @default.
• W3021855132 startingPage "2220" @default.
• W3021855132 abstract "Acute myeloid leukemia (AML) is among the top four malignancies in Saudi nationals, and it is the top leukemia subtype worldwide. Resistance to available AML drugs requires the identification of new targets and agents. Hsp90 is one of the emerging important targets in AML, which has a central role in the regulation of apoptosis and cell proliferation through client proteins including the growth factor receptors and cyclin dependent kinases. The objective of the first part of this study is to investigate the putative Hsp90 inhibition activity of three novel previously synthesized quinazolines, which showed HL60 cytotoxicity and VEGFR2 and EGFR kinases inhibition activities. Using surface plasmon resonance, compound 1 (HAA2020) showed better Hsp90 inhibition compared to 17-AAG, and a docking study revealed that it fits nicely into the ATPase site. The objective of the second part is to maximize the anti-leukemic activity of HAA2020, which was combined with each of the eleven standard inhibitors. The best resulting synergistic effect in HL60 cells was with the pan cyclin-dependent kinases (CDK) inhibitor dinaciclib, using an MTT assay. Furthermore, the inhibiting effect of the Hsp90α gene by the combination of HAA2020 and dinaciclib was associated with increased caspase-7 and TNF-α, leading to apoptosis in HL60 cells. In addition, the combination upregulated p27 simultaneously with the inhibition of cyclinD3 and CDK2, leading to abolished HL60 proliferation and survival. The actions of HAA2020 propagated the apoptotic and cell cycle control properties of dinaciclib, showing the importance of co-targeting Hsp90 and CDK, which could lead to the better management of leukemia." @default.
• W3021855132 created "2020-05-13" @default.
• W3021855132 creator A5001178856 @default.
• W3021855132 creator A5004512336 @default.
• W3021855132 creator A5008971418 @default.
• W3021855132 creator A5013795495 @default.
• W3021855132 creator A5018002037 @default.
• W3021855132 creator A5019048069 @default.
• W3021855132 creator A5022310620 @default.
• W3021855132 creator A5028698234 @default.
• W3021855132 creator A5054065490 @default.
• W3021855132 creator A5061395047 @default.
• W3021855132 creator A5068230459 @default.
• W3021855132 creator A5089443982 @default.
• W3021855132 creator A5090833833 @default.
• W3021855132 date "2020-05-08" @default.
• W3021855132 modified "2023-10-16" @default.
• W3021855132 title "Synergistic Anti Leukemia Effect of a Novel Hsp90 and a Pan Cyclin Dependent Kinase Inhibitors" @default.
• W3021855132 cites W1941646742 @default.
• W3021855132 cites W1976419927 @default.
• W3021855132 cites W2002851265 @default.
• W3021855132 cites W2003713667 @default.
• W3021855132 cites W2008492649 @default.
• W3021855132 cites W2021449313 @default.
• W3021855132 cites W2025396651 @default.
• W3021855132 cites W2030852779 @default.
• W3021855132 cites W2036150440 @default.
• W3021855132 cites W2036424091 @default.
• W3021855132 cites W2050941854 @default.
• W3021855132 cites W2060902443 @default.
• W3021855132 cites W2065551750 @default.
• W3021855132 cites W2071497118 @default.
• W3021855132 cites W2072568217 @default.
• W3021855132 cites W2074473216 @default.
• W3021855132 cites W2094872423 @default.
• W3021855132 cites W2096439168 @default.
• W3021855132 cites W2097786201 @default.
• W3021855132 cites W2109492343 @default.
• W3021855132 cites W2111817213 @default.
• W3021855132 cites W2115411710 @default.
• W3021855132 cites W2117941491 @default.
• W3021855132 cites W2135576690 @default.
• W3021855132 cites W2139306838 @default.
• W3021855132 cites W2141022069 @default.
• W3021855132 cites W2141715793 @default.
• W3021855132 cites W2142904379 @default.
• W3021855132 cites W2151222524 @default.
• W3021855132 cites W2162343852 @default.
• W3021855132 cites W2188633642 @default.
• W3021855132 cites W2316072843 @default.
• W3021855132 cites W2528689714 @default.
• W3021855132 cites W2529804753 @default.
• W3021855132 cites W2556999899 @default.
• W3021855132 cites W2625212592 @default.
• W3021855132 cites W2749127222 @default.
• W3021855132 cites W2749360928 @default.
• W3021855132 cites W2769060182 @default.
• W3021855132 cites W2790025101 @default.
• W3021855132 cites W2793053548 @default.
• W3021855132 cites W2799538976 @default.
• W3021855132 cites W2804264292 @default.
• W3021855132 cites W2921577938 @default.
• W3021855132 cites W2934059847 @default.
• W3021855132 cites W2954611200 @default.
• W3021855132 cites W2957197781 @default.
• W3021855132 cites W2965137695 @default.
• W3021855132 cites W2974308092 @default.
• W3021855132 cites W2976333264 @default.
• W3021855132 cites W2981095663 @default.
• W3021855132 cites W2992659008 @default.
• W3021855132 cites W3000653492 @default.
• W3021855132 cites W3013196158 @default.
• W3021855132 cites W363359229 @default.
• W3021855132 cites W4210407906 @default.
• W3021855132 doi "https://doi.org/10.3390/molecules25092220" @default.
• W3021855132 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7248782" @default.
• W3021855132 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32397330" @default.
• W3021855132 hasPublicationYear "2020" @default.
• W3021855132 type Work @default.
• W3021855132 sameAs 3021855132 @default.
• W3021855132 citedByCount "17" @default.
• W3021855132 countsByYear W30218551322020 @default.
• W3021855132 countsByYear W30218551322021 @default.
• W3021855132 countsByYear W30218551322022 @default.
• W3021855132 countsByYear W30218551322023 @default.
• W3021855132 crossrefType "journal-article" @default.
• W3021855132 hasAuthorship W3021855132A5001178856 @default.
• W3021855132 hasAuthorship W3021855132A5004512336 @default.
• W3021855132 hasAuthorship W3021855132A5008971418 @default.
• W3021855132 hasAuthorship W3021855132A5013795495 @default.
• W3021855132 hasAuthorship W3021855132A5018002037 @default.
• W3021855132 hasAuthorship W3021855132A5019048069 @default.
• W3021855132 hasAuthorship W3021855132A5022310620 @default.
• W3021855132 hasAuthorship W3021855132A5028698234 @default.
• W3021855132 hasAuthorship W3021855132A5054065490 @default.
• W3021855132 hasAuthorship W3021855132A5061395047 @default.
• W3021855132 hasAuthorship W3021855132A5068230459 @default.
• W3021855132 hasAuthorship W3021855132A5089443982 @default.

• next